Home /Research /OA13.06 Surgical Outcomes Following Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Non-Small Cell Lung Cancer - NEOSTAR Study
SURGICAL

OA13.06 Surgical Outcomes Following Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Non-Small Cell Lung Cancer - NEOSTAR Study

Boris Sepesi, Tina Cascone, William N. William, Heather Lin, Chun-Yuet Janice Leung, A. Weissferdt, G. Walsh, David C. Rice, Jack A. Roth, Reza J. Mehran, Wayne L. Hofstetter, Mara B. Antonoff, Frank V. Fossella, Frank E. Mott, Xiuning Le, Ferdinandos Skoulidis, J. Zhang, Lauren A. Byers, Vincent K. Lam, Bonnie S. Glisson

Year
2019
Citations
28
Access
Open access

Keywords

NivolumabMedicineIpilimumabPerioperativeLung cancerInternal medicineNeoadjuvant therapyPneumonectomyOncologySurgery

Related papers

Browse all SURGICAL papers